UA98909U - Method for immunocytochemical determination of pathological b-cells in the bone marrow and blood of patients with non-hodgkin lymphoma
- Google Patents
Method for immunocytochemical determination of pathological b-cells in the bone marrow and blood of patients with non-hodgkin lymphoma
Kavetskyi Inst Of Ex Pathology Oncology And Radiobiology Of Nas Of Ukraine
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Kavetskyi Inst Of Ex Pathology Oncology And Radiobiology Of Nas Of UkrainefiledCriticalKavetskyi Inst Of Ex Pathology Oncology And Radiobiology Of Nas Of Ukraine
Priority to UAU201412970UpriorityCriticalpatent/UA98909U/en
Publication of UA98909UpublicationCriticalpatent/UA98909U/en
Medicines Containing Material From Animals Or Micro-Organisms
(AREA)
Investigating Or Analysing Biological Materials
(AREA)
Abstract
Спосіб імуноцитохімічного визначення патологічних В-клітин в кістковому мозку і крові хворих на неходжкінські лімфоми шляхом визначення клітин лімфоми в клітинних препаратах крові (типу "висушеної краплі") та в мазках-препаратах із пунктату кісткового мозку за допомогою спеціально відібраної панелі МКАТ (моноклональних антитіл).Method for immunocytochemical determination of pathological B cells in bone marrow and blood of patients with non-Hodgkin's lymphoma by detecting lymphoma cells in blood cell preparations (type "dried droplets") and in smear preparations with bone marrow puncture using specially selected panels .
UAU201412970U2014-12-032014-12-03Method for immunocytochemical determination of pathological b-cells in the bone marrow and blood of patients with non-hodgkin lymphoma
UA98909U
(en)
isolated antibodies, isolated nucleic acid, host cell, methods of producing an antibody, treating cancer, treating a disease and detecting human jagged1 in a biological sample, immunoconjugate, pharmaceutical formulation and antibody use
antibodies, nucleic acid, host cell, antibody production method, immunoconjugate, pharmaceutical formulation, methods of detecting human lgr5 in a biological sample, detecting a cancer, identifying a cancer patient, selecting a patient with cancer for treatment with an immunoconjugate and treatment of a cancer patient